Paul Tudor Jones Adaptive Biotechnologies Corp Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 63,132 shares of ADPT stock, worth $214,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,132Holding current value
$214,017% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding ADPT
# of Institutions
200Shares Held
146MCall Options Held
2.6KPut Options Held
143K-
Viking Global Investors LP30MShares$102 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$43.6 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$39.2 Million0.35% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$37.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.6MShares$35.8 Million0.24% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $484M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...